Literature DB >> 9577421

Pseudomalignant heterotopic ossification.

F S Kaplan1, F H Gannon, G V Hahn, N Wollner, R Prauner.   

Abstract

Pseudomalignant heterotopic ossification is a rare, self limited connective tissue disorder of unknown origin that may occur atypically during childhood and can simulate either soft tissue sarcoma or fibrodysplasia ossificans progressiva. A complex constellation of diagnostic features usually enable the differentiation of pseudomalignant heterotopic ossification from extraosseous osteosarcoma and fibrodysplasia ossificans progressiva during a time span of approximately 8 to 12 weeks. Orthopaedic surgeons who treat children with connective tissue tumors should be familiar with pseudomalignant heterotopic ossification and its differential diagnosis. The occasional mild and variable expression of fibrodysplasia ossificans progressiva rarely may make it more difficult to distinguish from pseudomalignant heterotopic ossification. It is possible that pseudomalignant heterotopic ossification is a form fruste of fibrodysplasia ossificans progressiva.

Entities:  

Mesh:

Year:  1998        PMID: 9577421

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

Review 1.  Heterotopic ossification: a review.

Authors:  E F McCarthy; M Sundaram
Journal:  Skeletal Radiol       Date:  2005-08-25       Impact factor: 2.199

2.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

3.  Inhibition of osteogenic differentiation of human mesenchymal stem cells.

Authors:  Eduardo K Moioli; Liu Hong; Jeremy J Mao
Journal:  Wound Repair Regen       Date:  2007 May-Jun       Impact factor: 3.617

4.  Two cases of myositis ossificans in children, after prolonged immobilization.

Authors:  Victoria Kougias; Elpis Hatziagorou; Nikolaos Laliotis; Fotis Kyrvasillis; Vasiliki Georgopoulou; John Tsanakas
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-03-01       Impact factor: 2.041

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.